Percutaneous Valve Technologies, Inc. OBP III  
(Acquired by Edwards Lifesciences (EW))
Fort Lee, NJ
www.pvtechnologies.com

PVT is developing a replacement aortic heart valve capable of percutaneous transcatheter deployment, thereby creating a new treatment option for patients with aortic stenosis who can’t undergo open heart surgery.